Life Healthcare Group Limited provided consolidated earnings guidance for the six months ended 30 September 2020. The company announced investors that, based on a preliminary assessment of the unaudited consolidated management accounts of the group for the six months ended 30 September 2020 and information currently available to the Board, the group expects to record a profit of approximately HKD 1.7 million for the period as compared to a loss of approximately HKD 12.5 million for the corresponding period in 2019. The Board considers that the expected turnaround from net loss to net profit is primarily attributable to the following reasons: Due to the COVID-19 pandemic, the Company used its existing resources and expanded its arms to sales of medical equipment and epidemic prevention materials, which led to significant increase in revenue. Significant drop in administrative expense for the Period as some items of expenses were no longer incurred or were considerably reduced during the Period.